Daejeon, South Korea

Byung Chul Shin

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Daejun, KR (1992)
  • Daejeon-si, KR (2007)
  • Seoul, KR (2020)
  • Daejeon, KR (2005 - 2021)

Company Filing History:


Years Active: 1992-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Byung Chul Shin: Innovator in Cancer Treatment and Drug Delivery

Introduction

Byung Chul Shin is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of cancer treatment and drug delivery systems. With a total of 7 patents, his work focuses on innovative solutions that address critical health challenges.

Latest Patents

One of his latest patents is the "Anti-TM4SF4 antibody and uses thereof." This invention relates to novel antibodies or antigen-binding fragments that specifically bind to TransMembrane 4 Superfamily Member 4 (TM4SF4). These antibodies exhibit proliferation inhibitory activity against cancer cells, effectively preventing or treating cancer. They also reduce the self-renewal ability of cancer stem cells, making them useful in treating cancers with poor prognoses in conventional anticancer treatments.

Another significant patent is the "Microspherical sustained-release injection containing escitalopram and method for preparing same." This invention involves a biodegradable polymer microsphere-containing sustained-release injection with escitalopram as the active ingredient. The patent addresses challenges such as low encapsulation rates and initial over-release by maximizing encapsulation efficiency and controlling the release dynamics of the microspheres.

Career Highlights

Byung Chul Shin has worked with notable institutions, including the Korea Atomic Energy Research Institute and the Korea Research Institute of Chemical Technology. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Some of his coworkers include Sang Hyun Park and Kyung Bae Park. Their collaborative efforts have likely enhanced the research and development of his patented technologies.

Conclusion

Byung Chul Shin's innovative work in cancer treatment and drug delivery systems showcases his commitment to advancing medical science. His patents reflect a deep understanding of the challenges in these fields and offer promising solutions for future therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…